Neoadjuvant PD-1 plus Radiotherapy in Patients with Locally Advanced Hepatocellular Carcinoma: a Single Arm Study
Latest Information Update: 09 Jul 2024
At a glance
- Drugs Tislelizumab (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 04 Jun 2024 Results presented at the 60th Annual Meeting of the American Society of Clinical Oncology
- 04 Feb 2024 Status changed from not yet recruiting to completed.
- 29 Nov 2020 New trial record